glutathione colon cancer BRAFV600E in colorectal reduces sensitivity to oxidative stress and promotes site-specific metastasis by stimulating synthesis An injectable hydrogel for synergistic
An injectable hydrogel for synergistic therapy in colorectal cancer by targeting glutathione: Cell Reports Physical Science Molecular Medicine Reports Glutathione Reductase Expression and Its Prognostic Significance in Colon Cancer Frontiers Glutathione Peroxidase 4 as a Therapeutic Target for Anti Colorectal Cancer Drug Tolerant Persister Cells ACTL6A protects gastric cancer cells against ferroptosis through induction of glutathione synthesis Nature Communications Protein S glutathionylation induced by hypoxia increases hypoxia inducible factor 1 in human colon cancer cells ScienceDirect
Pay in 4 interest-free payments of $6.90 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7





